Neural transmission is a communication between neurons and target cells, resulting in behavioral and physiological changes. Defective or altered neural transmission is thought to occur in neuropsychiatric and neurodegenerative illnesses. To probe the biological consequences of defective or altered neural transmission, various genetically engineered transgenic mouse models have been developed, together with conventional pharmacological manipulation. Via genetic manipulation, we are able to engineer specific neurotransmitters, receptors, inactivation of neurotransmitters or neural innervation density. Moreover, recently developed molecular genetic techniques make it possible to induce either a gene knock out event or transgene expression at a discrete time point in a specific neuronal population in both embryos and adult animals. In conjunction with pharmacological manipulation, these sophisticated genetic manipulations of neural transmission will provide new tools to control neural transmission in both normal and pathophysiological conditions.
Introduction
of neurotransmitters in genetically engineered animal models. In genetically engineered transgenic mouse Neurons communicate with their target cells in models, we are able to alter neurotransmitter phenoresponse to environmental stimuli by releasing a limtype, either deplete or overproduce a specific neuroited quantity of information molecules, neurotransmittransmitter or a specific neurotransmitter receptor, ters, at their synaptic junctions. Specific receptors on inhibit the inactivation of neurotransmitters or regulate the target cell surface, linked to intracellular secondary innervation density. Since neural transmission occurs messenger systems, transduce extracellular inforthrough dynamic synaptic interactions between neuromation into the cell for further processing. Through transmitters and a number of specific receptors, the enzymatic inactivation and reuptake mechanisms, the availability of various animal models is essential for signaling role of the neurotransmitter is terminated.
the investigation of developmental, physiological and Thus, strict regulation of the flow of information via behavioral consequences of altered neural transneural transmission is crucial to the precise control of mission. These animal models may also reveal behavior and physiological functions. Defective or altunknown important roles of specific neurotransmitters ered neural transmission affecting normal information and may provide potential clinical implications. processing and storage is thought to occur in neuropsyIn this article we will focus on the monoamine syschiatric and neurodegenerative illness.
1-3 A number of tem. Catecholamine (CA, dopamine, norepinephrine drugs that modulate neural transmission have been utiand epinephrine) and serotonin (5-HT) systems are lized as pharmacological tools to probe the biological implicated in the pathophysiology of schizophrenia, consequences of altered neural transmission. While the depression, suicidal behavior, impulsive behavior, pharmacological approach has provided some insights, anxiety, anorexia and drug addiction. Moreover, their the lack of specificity of these pharmacological tools sequential biosynthetic pathways share common has not established conclusively the locus of action of enzymes, which provide a unique opportunity for genneurotransmitters and their receptors. The developetic alteration of specific neurotransmitter phenotype. ment of appropriate biological models therefore is As summarized in Figure 1 , dopamine is synthesized essential to an understanding of neural transmission at from l-tyrosine by tyrosine hydroxylase (TH) and aroboth the molecular and organismal levels. Recent promatic l-amino acid decarboxylase (AADC), which are gress in mouse genetics for manipulating the mouse present in all CA neurons. Dopamine ␤-hydroxylase genome 4,5 has provided ample opportunity to investi-(DBH) synthesizes norepinephrine with dopamine as gate developmental, physiological and behavioral roles substrate, which is localized in both noradrenergic and adrenergic neurons. The last enzyme phenylethanolamine N-methyltransferase (PNMT), a marker for adre- catalyzed by tryptophan hydroxylase (TPH) and tissues of transgenic mice. 9 The 6.1 kb of 5′ flanking promoter region was able to direct specific expression in transgenic mouse brain serotonergic cells and preferentially pineal gland. 10 Alteration of neurotransmitter phenotype Genetic alteration of noradrenergic neurons to adrenergic phenotype was attempted by simple overexpression of a single PNMT gene in noradrenergic cells of transgenic mice. 14, 15 The expression of the PNMT gene in brain and sympathetic ganglia induced de novo production of epinephrine and altered the level of norepinephrine and epinephrine in brain and blood. In brain noradrenergic/adrenergic cell bodies of epinephrine and epinephrine increased, whereas their brain target areas showed both increased PNMT activity and epinephrine release. In the sympathetic AADC. TPH is known as a specific marker enzyme for target tissues of the transgenic animals the level of epi-5-HT-producing cells.
nephrine was dramatically increased, but their norepinephrine levels were moderately decreased. 16 Thus, noradrenergic cells seemed to possess the basic Qualitative and quantitative manipulation of machinery required for the biosynthesis of epinephrine neurotransmitters except PNMT enzyme. However, complete conversion Neuron-specific promoter of norepinephrine to epinephrine did not occur in the To target desired genetic manipulations to phenotypetransgenic animals, probably due to either the prospecific neurons of transgenic animals, an essential duction of PNMT enzyme under the control of DBH step is to identify cell type-specific gene promoter/ promoter or tightly controlled neural homeostasis of enhancer regions. Identification of such DNA fragment CA levels. Interestingly, these alterations in CA specipermits neuron-specific genetic manipulations. Several ficity in transgenic mice led to down-regulation of the different groups including ours have characterized the binding sites and the steady-state mRNA level of ␤2-specific promoter regions for genetic manipulation in adrenergic receptor in the target tissues. Although any dopaminergic, noradrenergic, adrenergic, and serosubtle change in behavior or physiology has not yet tonergic neurons of the brain and peripheral nervous been fully addressed, the animal models used showed system (PNS) as summarized in Table 1 . For adult and that agonist-induced regulation of adrenergic receptor embryonic brain CA neurons, 9 kb of rat TH promoter may be one of the mechanisms to maintain neural region was able to direct high level, cell type-specific homeostasis. expression of a heterologous gene. [6] [7] [8] In noradrenergic When target cell neurotransmitter phenotype was cells 5.8 kb of human DBH promoter was sufficient to altered in transgenic mice, we observed the marked direct expression in noradrenergic and adrenergic reduction of target cell innervation density. 17 In this animal model we want to test the hypothesis that neurotransmitter phenotype of target cells is an important notion that the target neurotransmitter phenotype plays some role in the formation of neural connections became nearly normal. Thus, this animal model revealed that the neurotransmitter dopamine seems to during development.
be essential for movement, drinking and feeding behavior, but may not be critical for the development Overexpression Overproduction of neurotransmitters or their receptors of neural circuits controlling these behaviors. In the case of norepinephrine-deficient mice, most homoin transgenic mice was investigated to explore their therapeutic potential. For instance, overexpression of zygous embryos died in utero, and only a small number reached adulthood. Cardiovascular failure was the tyrosine hydroxylase (TH), the rate-limiting enzyme of CA biosynthesis 12 demonstrated potential application main cause of the death of the norepinephrinedeficient mutant. Together with TH-deficient mice, in mechanistic and physiological studies of neurotransmitter homeostasis. When human TH gene was these animal models lacking specific CA provide new means to examine the role of dopamine, norepioverexpressed in the brain and adrenal gland of transgenic mice, the level of TH mRNA was 50-fold higher nephrine and epinephrine in mammalian development, physiology and behavior. Those important data in brain and 5-fold higher in adrenal gland than that of endogenous mouse TH mRNA. Surprisingly, in this cannot be clearly obtained from classical pharmacological studies. transgenic mouse brain TH enzyme activity was only 2-to 5-fold higher than that of nontransgenic brain. Dopamine and norepinephrine levels in the transgenic mouse brain were not significantly changed from those in nontransgenic mice. Thus, TH enzyme activity Manipulation of neurotransmitter receptors seemed to be strictly regulated to maintain the neural homeostasis in transgenic brain. It is possible to reguAs described earlier, the animal model overexpressing the ␤2-adrenergic receptor 20 opened a unique way of late the intracellular second messenger system by overexpression of its receptor. For instance, cardiac-specific regulating the second messenger system linked to a specific receptor, which has important implications for overexpression of the ␤2-adrenergic receptor in transgenic mice increased atrial contractility and left venvarious neuropsychiatric illnesses. Another way to manipulate neural transmission is the targeted inactitricular function by the high concentration of cAMP, which was normally augmented by sympathetic norepvation of CA receptors or 5-HT receptors characterized by pharmacological studies. Often information inephrine or adrenal epinephrine. 20 During stress it is essential to increase catecholamine secretion and obtained from gene-targeted mutant mice is either confirmatory or contradicts our prediction based on pharstimulate myocardial ␤-adrenergic receptors for intensification of cardiac function. This animal model will macological studies. For example, to investigate the physiological role of the most abundant dopamine be clinically useful for the mechanistic study of chronic heart failure in humans, which is characterized receptors, D1 and D2, in dopaminergic neural transmission, transgenic mouse models lacking either D1 or by a marked reduction of myocardial ␤-adrenergic receptors. 21 Also, the model implies that regulation of D2 receptor were generated using homologous recombination. [25] [26] [27] [28] The animals lacking D1 receptor exhiba second messenger system linked to a specific neurotransmitter receptor can be achieved by a controlled ited either normal behavior or locomotor hyperactivity, in contrast to pharmacological studies using D1 recepexpression of the receptor molecules in specific cells of the brain and periphery.
tor antagonists exerting suppressive effect. This approach revealed the essential role of the D1 receptor in the locomotor stimulant effects of cocaine. The D2 Depletion by gene knock out The knock out of a specific CA biosynthesis enzyme receptor-deficient mouse demonstrated akinetic and bradykinetic behaviors and lack of spontaneous movegene, in conjunction with gene knock in, enabled the generation of mutant mice lacking only dopamine, 22 ment as predicted from D2 antagonist treatment.
The serotonergic system modulates key physiologinorepinephrine and epinephrine 23 or all three CA. 24 The dopaminergic system in brain has major roles in cal functions including appetite, motor activity, sleep, sexual activity, learning and memory and has been the regulation of movement, cognitive, reward and emotional behavior and is implicated in the pathophyassociated with mood disorders. Recent studies have identified more than 14 mammalian 5-HT receptors siology of Parkinson's disease, schizophrenia, depression and drug addiction. The dopamineand several isoforms of known 5-HT receptors. 29 Thus, gene targeting technology became a major player to deficient mice were generated by both targeted disruption of TH gene and restoring TH activity only in norinvestigate the physiological role of serotonergic neural transmission, revealing some unexpected functions of adrenergic and adrenergic cells. The brains of newborn dopamine-deficient mice displayed no more obvious these receptors. The mutant mouse lacking the 5-HT 1B showed enhanced aggressive behavior, which suganatomical deficiencies except reduced brain size, possibly as a result of neuronal compaction, than those gested the involvement of 5-HT 1B receptor in aggressive behavior. 30 Of interest, the mutant mouse lacking 5-of wild-type mice. 22 Dopamine-deficient animals failed to thrive and died during postnatal week 3 due to HT 2C was overweight due to abnormal feeding behavior and might have been prone to spontaneous death hypoactivity and aphagia. When l-DOPA was administered continuously, locomotion and food consumption from seizures.
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Manipulation of neurotransmitter inactivation
density as well as the regulation of synaptic efficacy. [39] [40] [41] Therefore, appropriate genetic manipulation of the mechanisms expression of neurotrophic factors will be another way To alter the termination of neural transmission, mice to modulate neural transmission in animal models. lacking monoamine oxidase A (MAOA) were generated by insertional mutation. 32 Enhanced aggression was Future direction and implications manifested by adult male mice. In pup brain 5-HT and norepinephrine concentrations were increased up to 9-Pharmacological manipulation of neural transmission fold and 2-fold, respectively. Thus, the dramatically has been an important tool to probe neuronal comaltered 5-HT metabolism seemed to be linked to severe munication in the nervous system. It has unraveled the behavioral abnormalities. In fact, a point mutation in defective neural transmission underlying various neurthe eighth exon of human MAOA gene, which abolopsychiatric and neurodegenerative illnesses which ished MAOA catalytic activity, is known to be associaled to the development of new drugs to improve neuroted with impulsive aggression in affected men. 33 pathological conditions. However, the inherent experiThe dopamine transporter has an important role in mental limitation of pharmacological manipulation locomotion, cognition, affect and neuroendocrine funcsuch as lack of drugs with sufficient specificity and diftions by controlling rapid uptake of released dopamine ficulty in localized drug delivery, necessitated the molecules. Thus, it is a target site for antidepressants, employment of complementary approaches, such as cocaine and amphetamines. In the mouse model lackthe recently developed genetic approach to study neuing the dopamine transporter, the released dopamine ral transmission in vivo. For instance, pharmacological lasted 100 times longer, resulting in spontaneous hyptreatment with a D1 receptor antagonist produces an erlocomotion. 34 Moreover, psycostimulants, cocaine acute and partial inhibition, in contrast to the genetic and amphetamines, have no effect in this animal knock out of D1 receptor, clearly resulting in a permamodel. Therefore, the genetic regulation of either MAO nent and complete inhibition. Another cause of the enzymes' activities or monoamine transporter level can functional discrepancy between pharmacological be an essential tool to modulate neural transmission.
manipulation and genetic manipulation is that transgenic mouse mutants, carrying either new transgenes or a targeted gene knock out, can be often compensated Manipulation of neural innervation by up-or down-regulation of the related gene family during embryonic development. Therefore, the phenoNeonatal cell death of nigrostriatal dopaminergic neurons produced by 6-hydroxydopamine administration type of transgenic mouse models could be a mere consequence of developmental abnormality, instead of resulted in serotonergic hyperinnervation of striatum from the dorsal raphe nucleus. 35 The serotonergic hypthe physiological role of a targeted gene product per se. Recent development of molecular genetic techniques erinnervation increased the capacity of 5-HT release by 3-fold in the striatum of the neonatally dopaminemakes it possible to circumvent this problem by spatiotemporal regulation of a gene-targeting or transgene depleted rat. But the resting level of 5-HT in extracellular fluid of the striatum was not different from that in expression. For instance, an inducible and/or tissuespecific knock out is technically possible to initiate a intact rats due to the concomitant increase in highaffinity 5-HT uptake. Our characterized neurodevelopgene-targeting event at a discrete time point in a specific neuronal population in adult animals, which mental mouse mutant, Anorexia (anx), exhibited anorexic starvation and abnormal behaviors (body tremors, experience no specific mutation during development. 42, 43 Moreover, using the inducible tetracycline hyperactivity, abnormal gait and headweaving), which resemble phenomena induced by pharmacological binary system, specific gene expression can be induced with spatiotemporal control in transgenic mice. 44 overstimulation of 5-HT receptors. 36 Immunohistochemical analysis of anx brain revealed extensive seroThese powerful genetic tools will allow us to generate more sophisticated animal models, which will provide tonergic hyperinnervation in its normal target fields, such as hippocampus, cortex, olfactory bulb and cereunprecedented insights into neural transmission underlying brain function, behavior and physiology. bellum, which seemed to increase 5-HT release. Noradrenergic hyperinnervation from locus ceruleus was observed in terminal fields of Tottering (tg) mouse References mutant with a concomitant increased level of norad- 
